Clinical Guidelines

Offer evidence-based recommendations for clinicians about the care of patients.

Office-Based Addiction Treatment Training and Technical Assistance Medication Assisted Treatement Quick Start

The BMC MAT Quick Start App utilizes interactive clinical algorithms to walk clinicians through each step of the medication initiation process and pain management recommendations for patients with OUD. The app does not replace clinical decision-making and is meant to help inform clinicians regarding the use of medications for opioid use disorder.

Best Practices for Designing and Implementing Substance Use Disorder (SUD)-Focused Health Homes

This document provides a description of some best practices for designing and implementing a Substance Use Disorder (SUD)-focused health home state plan amendment based on the experiences of states with approved SUD-focused health home programs as required per section 1006(a)(2) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-271).

FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency

SAMHSA recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance on the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency for Opioid Treatment Programs.

Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management

This part of the guidelines is intended to assist PC clinicians in the identification and initial management of adolescents with depression in an era of great clinical need and shortage of mental health specialists, but they cannot replace clinical judgme